Search

everythinglearnresearchcommunity

for

Search:↓

Advancements in creating skin grafts with biomaterials and stem cells are promising, but more research is needed for clinical application.

The protein SLC1A3 is important for activating skin stem cells and is necessary for normal hair and skin growth in mice.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Melanoma development can be linked to the breakdown of skin's melanin-producing units.

Polycomb Repressive Complex 2 is not needed for hair regeneration.

KLF4 is important for maintaining stem cells and has potential in cancer treatment and wound healing.

The Megsin-Cre transgene is a new tool for genetic manipulation in the skin and upper digestive tract.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

Different fish use the same genes to regrow teeth.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

ANA-negative lupus nephritis can be diagnosed and treated effectively with a comprehensive approach.

Different species use the same genes for tooth regeneration.

Maritime pine bark has various chemical components useful for different industrial uses.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Cultured dermal papilla cells can regenerate hair follicles and sustain hair growth.

EGF controls hair growth by regulating hair follicles' growth phases.

HS patients rarely see dermatologists, often get opiates, and need better care.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

Psoriasis increases annual healthcare costs by $4,044 per patient, with biologic treatments costing significantly more than phototherapy.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.